Sign In
Buy BXP
$70.67
+0.260 (+0.369%)
At Close: Aug 04, 2026
A Tale of Two Office Buildings: Quality Is the Key to Enticing Employees to Return to the Office
01:30pm, Friday, 13'th May 2022 The Motley Fool
Companies are finding that they need the right space to get their employees to come back to the office.
A Tale of Two Office Buildings: Quality Is the Key to Enticing Employees to Return to the Office
09:30am, Friday, 13'th May 2022
Companies are finding that they need the right space to get their employees to come back to the office.
Rayonier (RYN) Q1 FFO Beats Estimates, Revenues Rise Y/Y
01:03pm, Thursday, 05'th May 2022 Zacks Investment Research
Rayonier's (RYN) Q1 top line rises year over year, backed by strong results in the Southern Timber, Pacific Northwest Timber and Real Estate segments.
Realty Income's (O) Q1 FFO and Revenues Outpace Estimates
12:23pm, Thursday, 05'th May 2022 Zacks Investment Research
Realty Income's (O) first-quarter 2022 results display top-line growth. It benefits from expansionary effects and a healthy pipeline of opportunities globally.
Host Hotels (HST) Beats on Q1 FFO & Revenues, Doubles Dividend
11:52am, Thursday, 05'th May 2022 Zacks Investment Research
Host Hotels' (HST) Q1 results pick-up on rising demand for leisure travel and room rates, which surpassed 2019 figures. It also announced doubling of its quarterly dividend.
Extra Space Storage's (EXR) Q1 FFO Beats, Occupancy Falls
02:16pm, Wednesday, 04'th May 2022 Zacks Investment Research
Extra Space Storage (EXR) posts strong first-quarter top-line growth partially offset by lower occupancy and higher same-store expenses. It also raises its 2022 outlook.
Regency Centers (REG) Beats on Q1 FFO & Revenues, Raises View
01:55pm, Wednesday, 04'th May 2022 Zacks Investment Research
Regency Centers' (REG) first-quarter 2022 results depict higher-than-anticipated top-line growth and robust leasing activity.
Healthpeak's (PEAK) Q1 FFO & Revenues Beat Estimates, NOI Up
12:54pm, Wednesday, 04'th May 2022 Zacks Investment Research
Healthpeak's (PEAK) Q1 results reflect higher same-store portfolio cash (adjusted) net operating income on improved life-science, medical office and continuing care retirement communities portfolios.
Boston Properties, Inc. (BXP) CEO Owen Thomas on Q1 2022 Results - Earnings Call Transcript
03:13pm, Tuesday, 03'rd May 2022
Boston Properties, Inc. (NYSE:BXP ) Q1 2022 Earnings Conference Call May 3, 2022 11:00 AM ET Company Participants Helen Han - Vice President, Investor Relations Owen Thomas - Chief Executive Officer D
Boston Properties (BXP) Q1 FFO Beats, Leasing Momentum Strong
02:47pm, Tuesday, 03'rd May 2022 Zacks Investment Research
Boston Properties' (BXP) witnesses higher top line and strong leasing momentum in the first quarter.
Boston Properties (BXP) Q1 FFO Beats, Leasing Momentum Strong
12:02pm, Tuesday, 03'rd May 2022
Boston Properties' (BXP) witnesses higher top line and strong leasing momentum in the first quarter.
Boston Properties (BXP) Beats Q1 FFO and Revenue Estimates
10:15pm, Monday, 02'nd May 2022 Zacks Investment Research
Boston Properties (BXP) delivered FFO and revenue surprises of 4.60% and 2.51%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
7 Stocks to Sell Ahead of the Fed's Next Rate Hike
03:36pm, Monday, 02'nd May 2022
The upcoming Fed meeting on an interest rate hike can negatively impact the stock market. Thus, I have found seven vulnerable stocks to sell.
CTO Realty (CTO) Surpasses Q1 FFO and Revenue Estimates
09:45pm, Thursday, 28'th Apr 2022 Zacks Investment Research
CTO Realty (CTO) delivered FFO and revenue surprises of 38.32% and 0.27%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
Piedmont Office (PDM) Meets Q1 FFO Estimates
09:45pm, Wednesday, 27'th Apr 2022 Zacks Investment Research
Piedmont Office (PDM) delivered FFO and revenue surprises of 0% and 0.20%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
